Day Trading with Harry Boxer

Day Trading, stock picks & technical analysis with Harry Boxer

EYES, FEYE, TGTX, ZIOP - Stock Charts to Watch RSS

Charts of the Day video for Wed February 25th 2015

Public Charts of the Day
It was an interesting day on Wall....

What are Harry’s Top Picks for 2015? Sign up now and find out!

It was an interesting day on Wall Street, up nicely in the morning to new all-time highs, and then rolled them over, and rolled them over hard before a late bounce. Perhaps it’s a sign that the market wants to take a rest, but we’ll just have to wait and see what happens in the next few days.

Second Sight Medical Products, Inc. (EYES) has had two consecutive big days with big volume. It broke through resistance on Wednesday, up 2.70 to 13.90, or 24%, on 9.8 million shares. The next target on EYES if it gets a follow-through is 16-16 1/4-1/2. But at some point shortly it’s going to get some pullback consolidation.

FireEye, Inc. (FEYE) was up 1.43 to 45.40, or 31/4%, on 15.7 million shares. This stock has had some very nice action after the run-up and break out of the base. The pullback has held some four or five days now above the 42 1/2 range. If it can get above the recent spike high at 46.18, it could see 50-51, which is the next target.

TG Therapeutics, Inc. (TGTX) popped 1.51 to 15.26 or 11%, on 1.25 million shares on Wednesday. That’s the best volume in two months. The next target on this one should it extend will be up to 15 1/2, and the double-top at 18.

ZIOPHARM Oncology, Inc. (ZIOP) had a run-up late in the day on Wednesday, up 60 cents to right near the high for the day at 10.50, or 6%, on 3.3 million shares. This looks like an accelerating, rising flag that could explode toward 14 1/2-15 short-term target.

Other stocks on Harry’s Charts of the Day included Advaxis, Inc. (ADXS), Biocept, BroadSoft, Inc. (BIOC), BroadSoft, Inc. (BSFT), EPIRUS Biopharmaceuticals, Inc. (EPRS), First Solar, Inc. (FSLR), Helios and Matheson Analytics Inc. (HMNY), Nuverra Environmental Solutions, Inc. (NES), Opko Health, Inc. (OPK), Regulus Therapeutics Inc. (RGLS), the Rubicon Project, Inc. (RUBI), and Sorrento Therapeutics, Inc. (SRNE).